Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; hypromellose; magnesium stearate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - gliclazide 60 mg - modified-release tablet - 60 mg - gliclazide 60 mg - gliclazide

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaforte (malaysia) sdn. bhd. - gliclazide -

Canada - English - Health Canada

teva canada limited - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Canada - English - Health Canada

mylan pharmaceuticals ulc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Canada - English - Health Canada

pharmascience inc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Canada - English - Health Canada

apotex inc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Canada - English - Health Canada

nu-pharm inc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Canada - English - Health Canada

sanis health inc - gliclazide - tablet (extended-release) - 60mg - gliclazide 60mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - gliclazide 60 mg - modified-release tablet - 60 mg - gliclazide 60 mg - gliclazide